- cafead Aug 29, 2023 at 11:52: AM
via Apellis Pharmaceuticals is laying off one quarter of its workforce in an overhaul of its business designed to focus resources on a newly approved vision loss drug.
The job cuts announced Tuesday will affect about 225 employees. The company’s field-based sales staff and medical employees are “minimally affected” by the reorganization, which will be completed during the third quarter, Apellis said.
article source
The job cuts announced Tuesday will affect about 225 employees. The company’s field-based sales staff and medical employees are “minimally affected” by the reorganization, which will be completed during the third quarter, Apellis said.
article source